Medicare Enrolled
Dr. Richard Wright, M.D.
Cardiovascular Disease · Santa Monica, CA
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Speaking/Promotional
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Wright from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Wright?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Wright
Dr. Richard Wright is a cardiovascular disease specialist in Santa Monica, CA, with 20 years of NPI registration. Based on federal Medicare data, Dr. Wright performed 15,999 Medicare services across 2,719 unique beneficiaries.
Between the years covered by Open Payments, Dr. Wright received a total of $1,610,502 from 51 pharmaceutical and/or device companies across 2141 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in cardiovascular disease. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Wright is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice
▲ Top 3% volume in CA
$1,610,502 industry payments
Medicare Practice Summary
Medicare Utilization ↗15,999
Medicare services
Top 3% in CA for cardiovascular disease
2,719
Unique beneficiaries
$22
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~800 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Inclisiran injection (Leqvio) for cholesterol | 12,212 | $9 | $34 |
| Electrocardiogram (EKG), 12-lead A standard heart rhythm test using at least 12 leads to record electrical activity. A healthcare provider interprets the results and provides a written report. |
1,476 | $12 | $132 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
627 | $98 | $619 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
533 | $146 | $864 |
| Echocardiogram, transthoracic An ultrasound of the heart that uses color to show blood flow, rate, direction, and valve function. |
168 | $174 | $999 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
160 | $8 | $15 |
| Heart muscle strain imaging | 117 | $35 | $189 |
| Ambulatory blood pressure monitoring, 1 day or longer This procedure involves wearing a device to record blood pressure over a day or longer. It includes analyzing the data, interpreting the results, and providing a report. |
116 | $38 | $230 |
| Continuous EKG monitoring review, 48-7 days Review and interpretation of continuous external EKG recordings lasting more than 48 hours up to 7 days. |
79 | $19 | $110 |
| Continuous external EKG monitoring, 48 hours to 7 days This procedure involves recording the heart's electrical activity continuously using an external device for a period exceeding 48 hours but not more than 7 days. |
67 | $11 | $63 |
| 2-day continuous ECG with review and report A two-day continuous electrocardiogram recording that includes a professional review and written report of the results. |
61 | $61 | $372 |
| New patient office visit, complex (60-74 min) | 60 | $174 | $1,055 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
53 | $68 | $371 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
46 | $13 | $70 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
43 | $100 | $558 |
| Office visit for established patient An office visit for an existing patient that may not require the healthcare professional to be present. |
36 | $19 | $117 |
| EKG interpretation and report A standard electrocardiogram test that records the heart's electrical activity using at least 12 leads. The service includes a professional interpretation of the results and a written report. |
33 | $7 | $38 |
| Ultrasound of head and neck blood flow, bilateral An ultrasound exam that uses sound waves to visualize and assess blood flow in the vessels of both the head and the neck. |
28 | $167 | $986 |
| Telephone medical discussion, 21-30 minutes A telephone conversation with a physician lasting between 21 and 30 minutes. This code covers the time spent discussing medical matters over the phone. |
19 | $113 | $616 |
| Flu vaccine, quadrivalent A flu shot containing four strains of the influenza virus to help prevent seasonal influenza infection. |
17 | $76 | $348 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
17 | $149 | $814 |
| Flu vaccine administration This procedure involves the administration of the influenza virus vaccine. It covers the process of delivering the vaccine to the patient. |
17 | $34 | $60 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
14 | $111 | $609 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
1.1% high complexity
77.5% medium
21.4% routine
Industry Payment Transparency
Open Payments through 2024 ↗$1,610,502
Total received (2018-2024)
Avg $230,072/year across 7 years
Top 0% in CA for cardiovascular disease
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
51
Companies
2,141
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$1,589,994 (98.7%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$13,606 (0.8%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$6,902 (0.4%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$386,894
2023
$277,370
2022
$166,246
2021
$105,817
2020
$133,998
2019
$298,455
2018
$241,721
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
E.R. Squibb & Sons, L.L.C.
$122,618
Alnylam Pharmaceuticals Inc.
$82,244
AstraZeneca Pharmaceuticals LP
$69,934
Lexicon Pharmaceuticals, Inc.
$38,940
Boehringer Ingelheim Pharmaceuticals, Inc.
$25,351
Amgen Inc.
$22,129
Novartis Pharmaceuticals Corporation
$13,358
PFIZER INC.
$6,796
Lilly USA, LLC
$5,163
Merck Sharp & Dohme LLC
$88
Janssen Pharmaceuticals, Inc
$84
Kiniksa Pharmaceuticals International, plc
$45
Regeneron Healthcare Solutions, Inc.
$35
Impulse Dynamics (USA) Inc.
$27
Novo Nordisk Inc
$22
Boston Scientific Corporation
$22
Recor Medical Inc
$21
HEARTFLOW, INC.
$15
Top 3 companies account for 71.0% of 2024 payments
All-time payments by company (2018-2024) ›
Amgen Inc.
$440,043
E.R. Squibb & Sons, L.L.C.
$305,022
Boehringer Ingelheim Pharmaceuticals, Inc.
$287,189
Novartis Pharmaceuticals Corporation
$191,601
Alnylam Pharmaceuticals Inc.
$90,610
Akcea Therapeutics, Inc.
$84,004
AstraZeneca Pharmaceuticals LP
$80,611
Lexicon Pharmaceuticals, Inc.
$38,965
Lilly USA, LLC
$29,038
Boston Scientific Corporation
$26,068
NOVARTIS PHARMACEUTICALS CORPORATION
$10,797
PFIZER INC.
$9,672
SANOFI-AVENTIS U.S. LLC
$8,356
Eli Lilly and Company
$3,575
Abbott Laboratories
$872
Janssen Pharmaceuticals, Inc
$789
Regeneron Healthcare Solutions, Inc.
$621
ABIOMED
$464
Edwards Lifesciences Corporation
$218
Otsuka America Pharmaceutical, Inc.
$164
Kiniksa Pharmaceuticals, Ltd.
$163
Terumo Medical Corporation
$150
Bayer Healthcare Pharmaceuticals Inc.
$143
Vifor Pharma, Inc.
$126
Takeda Pharmaceuticals U.S.A., Inc.
$123
CVRx, Inc.
$121
Merck Sharp & Dohme LLC
$119
AbbVie Inc.
$104
Actelion Pharmaceuticals US, Inc.
$102
Amarin Pharma Inc.
$96
Lundbeck LLC
$63
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$60
Kiniksa Pharmaceuticals International, plc
$45
Daiichi Sankyo Inc.
$43
Lantheus Medical Imaging, Inc.
$38
Arbor Pharmaceuticals, Inc.
$30
CathWorks, Inc.
$29
Impulse Dynamics (USA) Inc.
$27
Aegerion Pharmaceuticals, Inc.
$25
Novo Nordisk Inc
$22
CSL Behring
$21
ARBOR PHARMACEUTICALS, INC.
$21
Recor Medical Inc
$21
Amryt Pharma Holdings Ltd
$20
Allergan Inc.
$20
SCPHARMACEUTICALS INC.
$18
HeartFlow, Inc.
$16
GE HEALTHCARE
$15
HEARTFLOW, INC.
$15
Medtronic USA, Inc.
$15
Medtronic Vascular, Inc.
$13
Top 3 companies account for 64.1% of all-time payments
Associated products mentioned in payments ›
AMVUTTRA · AQUAMANTYS · AVEIR · Arcalyst · BRILINTA · BYSTOLIC · Barostim Neo System · BodyGuardian · CAMZYOS · Confirm Rx · Corlanor · DEFINITY · DISEASE STATE · DUPIXENT · ELIQUIS · EMBLEM · ENTRESTO · EVENITY · EVKEEZA · Edarbi · Edwards SAPIEN 3 Transcatheter Heart Valve · FARXIGA · FFRangio System · FFRct · FUROSCIX · GENERAL THERAPIES · GENERAL THERAPIES · HeartMate 3 Left Ventricular Dev · INJECTAFER · Impella · Inpefa · JARDIANCE · JUXTAPID · JYNARQUE · Juxtapid · Kcentra · Kerendia · LEQVIO · LifeVest · MOUNJARO · Mitra Clip system · MitraClip System · NORTHERA · ONPATTRO · Optimizer · Optitorque · PARADISE RENAL DENERVATION SYSTEM · PRADAXA · PRALUENT · PRALUENT ALIROCUMAB INJECTION · Perclose ProGlide suture mediated closure system · Quadra Assura CRT Defibrillator · Repatha · Reveal LINQ · SAMSCA · TEGSEDI · THERAPIES · TRULICITY · UBRELVY · UPTRAVI · VERQUVO · VYNDAMAX · VYNDAQEL · VYVANSE · Vascepa · Veltassa · WAINUA · WATCHMAN · WATCHMAN Access System · Wegovy · XARELTO
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
The majority of payments (99%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in cardiovascular disease and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 0% for cardiovascular disease in CA.
Geographic Context
Cardiologists within 10 mi
555
Per 100K population
5.6
County median income
$87,760
Nearest hospital
SANTA MONICA - UCLA MED CTR & ORTHOPAEDIC HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Wright is a mixed practice specialist, with above-average Medicare volume (top 3% in CA), with speaking/promotional industry engagement in the top 0% of CA peers, with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Wright experienced with inclisiran injection (leqvio) for cholesterol?
Based on Medicare claims data, Dr. Wright performed 12,212 inclisiran injection (leqvio) for cholesterol services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Wright receive payments from pharmaceutical companies?
Yes. Dr. Wright received a total of $1,610,502 from 51 companies across 2,141 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Wright's costs compare to other cardiologists in Santa Monica?
Dr. Wright's average Medicare payment per service is $22. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Wright) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Cardiologists in Santa Monica
Browse cardiologists in Santa Monica ranked by procedure volume and transparency data.
Highest volume
Top Cardiologists in CA
Cardiologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Cardiologists in CA
Which CA cardiologists receive the most from drug and device companies.
By company
Amgen Inc. Payments to Doctors
See all physicians who received payments from Amgen Inc.
By company
E.R. Squibb & Sons, L.L.C. Payments to Doctors
See all physicians who received payments from E.R. Squibb & Sons, L.L.C.
By company
Boehringer Ingelheim Pharmaceuticals, Inc. Payments to Doctors
See all physicians who received payments from Boehringer Ingelheim Pharmaceuticals, Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology